Max Perutz Labs Vienna
Markus Hartl is an accomplished scientist with extensive experience in mass spectrometry and plant biology. Currently serving as the Head of Mass Spectrometry Service at Max Perutz Labs Vienna since May 2014, Markus has a strong research background highlighted by a guest scientist role at the Max Planck Institute for Biochemistry from May 2012 to April 2014, where collaboration focused on lysine acetylation. Prior to that, Markus worked as a postdoc at Ludwig-Maximilians Universität München from August 2010 to December 2013, investigating post-translational modifications in plant metabolite signaling, and at the Max Planck Institute for Chemical Ecology in early 2010, researching serine protease inhibitors in plant defense. Markus earned a Dr. rer. nat. in Plant Biology from the Max Planck Institute for Chemical Ecology and a Diplom in Biology and Ecology from the University of Vienna.
Max Perutz Labs Vienna
The Max Perutz Labs are a joint venture between the University of Vienna and the Medical University of Vienna that builds on the unique opportunities that arise from being embedded in the Vienna BioCenter Campus while having one of the largest hospitals in Europe, the Vienna General Hospital, on our doorstep. In visualizing haemoglobin, Max Perutz paved the way towards the era of precision medicine. To realize its full potential, precision medicine necessitates a molecular mechanistic approach. Research at the Max Perutz Labs is curiosity-driven and spans the fields of molecular and cell biology. Most groups investigate basic research questions but a significant number are also active in more applied fields of biology. The Max Perutz Labs seek to educate students to think critically and analytically, challenge them to set ambitious goals, and instill in them both broad horizons and deep understanding. In doing so, we aspire to furnish them with the necessary knowledge and skills to push forward the frontiers of 21st century biomedical science.